Abstract
Original Investigation Use of Expedited Drug Development and Review Programs by Novel Drugs in the US Andrea N. Monge, MD, PhD; Daniel W. Sigelman, JD; Robert J. Temple, MD; Harinder Singh Chahal, PharmD, MSc
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.